To address this hypothesis, we have comprehensively evaluated the clinicopathological significance of the CDK2, CDK4, CDK6, cyclin D1, cyclin E1, RB1 and pRB1(Ser 795) protein expression in a clinical cohort of epithelial ovarian cancer. The gene discussed is PRB1; the disease is ovarian carcinoma.